Phosphorites

First International Field Workshop and Seminar on Proterozoic-Cambrian Phosphorites, held in Australia, August 197

Investigating the Correlation between Performance Scores and Energy Consumption of Mobile Web Apps

Context. Developers have access to tools like Google Lighthouse to assess the performance of web apps and to guide the adoption of development best practices. However, when it comes to energy consumption of mobile web apps, these tools seem to be lacking. Goal. This study investigates on the correlation between the performance scores produced by Lighthouse and the energy consumption of mobile web apps. Method. We design and conduct an empirical experiment where 21 real mobile web apps are (i) analyzed via the Lighthouse performance analysis tool and (ii) measured on an Android device running a software-based energy profiler. Then, we statistically assess how energy consumption correlates with the obtained performance scores and carry out an effect size estimation. Results. We discover a statistically significant negative correlation between performance scores and the energy consumption of mobile web apps (with medium to large effect sizes), implying that an increase of the performance score tend to lead to a decrease of energy consumption. Conclusions. We recommend developers to strive to improve the performance level of their mobile web apps, as this can also have a positive impact on their energy consumption on Android devices

『シャベール大佐』における「語り手」について

Examen des etapes textuelles du Colonel Chabert. Qui raconte > a qui dans cette nouvelle? Analyse du > dans Le Colonel Chabert de Balzac au point de depart d\u27une remarque de Peter Brooks sur >

『ゴプセック』における語りの構造について

Examen des Rapes textuelles de Gobseck. Analyse de la structure narrative de Gobseck de Balzac d\u27apres quelques remarques de Bernard Lalande, de Pierre Citron et de Pierre Barberis. Role du > joue dans Gobseck

Congenital hypothyroidism

Congenital hypothyroidism (CH) occurs in approximately 1:2,000 to 1:4,000 newborns. The clinical manifestations are often subtle or not present at birth. This likely is due to trans-placental passage of some maternal thyroid hormone, while many infants have some thyroid production of their own. Common symptoms include decreased activity and increased sleep, feeding difficulty, constipation, and prolonged jaundice. On examination, common signs include myxedematous facies, large fontanels, macroglossia, a distended abdomen with umbilical hernia, and hypotonia. CH is classified into permanent and transient forms, which in turn can be divided into primary, secondary, or peripheral etiologies. Thyroid dysgenesis accounts for 85% of permanent, primary CH, while inborn errors of thyroid hormone biosynthesis (dyshormonogeneses) account for 10-15% of cases. Secondary or central CH may occur with isolated TSH deficiency, but more commonly it is associated with congenital hypopitiutarism. Transient CH most commonly occurs in preterm infants born in areas of endemic iodine deficiency. In countries with newborn screening programs in place, infants with CH are diagnosed after detection by screening tests. The diagnosis should be confirmed by finding an elevated serum TSH and low T4 or free T4 level. Other diagnostic tests, such as thyroid radionuclide uptake and scan, thyroid sonography, or serum thyroglobulin determination may help pinpoint the underlying etiology, although treatment may be started without these tests. Levothyroxine is the treatment of choice; the recommended starting dose is 10 to 15 mcg/kg/day. The immediate goals of treatment are to rapidly raise the serum T4 above 130 nmol/L (10 ug/dL) and normalize serum TSH levels. Frequent laboratory monitoring in infancy is essential to ensure optimal neurocognitive outcome. Serum TSH and free T4 should be measured every 1-2 months in the first 6 months of life and every 3-4 months thereafter. In general, the prognosis of infants detected by screening and started on treatment early is excellent, with IQs similar to sibling or classmate controls. Studies show that a lower neurocognitive outcome may occur in those infants started at a later age (> 30 days of age), on lower l-thyroxine doses than currently recommended, and in those infants with more severe hypothyroidism